Last reviewed · How we verify
NCT05781282
Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation
Phase 4 trial testing Atrial fibrillation ablation in Atrial Fibrillation Recurrent in 18 participants. Status unknown.
1 January 2024
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 1 November 2021 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Atrial fibrillation ablation
Conditions studied
- Atrial Fibrillation Recurrent — all drugs for Atrial Fibrillation Recurrent →
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Who can join
Adults 18 to 80, any sex, with Atrial Fibrillation Recurrent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To test the hypothesis that structural changes documented by ICE after pulmonary vein deconnection by RF can predict AF recurrences
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05781282
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Atrial fibrillation ablation
Trials testing the same drug.
- NCT07159685 — Sex-Based Differences of LA: Impact on AF Ablation. · not yet recruiting
- NCT06620575 — Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation · completed
- NCT06497933 — Exhaustive French National Registry of AF Ablation Using Pentaspline Pulsed Field Ablation Catheter · active not recruiting
- NCT04649801 — Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplanta · NA · completed
- NCT05319769 — Non Fluoroscopic APpROach iN atriaL Fibrillation Ablation procEdureS · completed
Other recruiting trials for Atrial Fibrillation Recurrent
Currently open trials in the same condition.
- NCT06111443 — Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial F · Phase 2, PHASE3 · active not recruiting
- NCT06253000 — Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium · NA · recruiting
- NCT05266144 — Atrial Fibrillation Patients Treated With Catheter Ablation · recruiting
Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials
Trials by the same sponsor.
- NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
- NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
- NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
- NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
- NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05781282 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Last refreshed: 27 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05781282.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing